GlassScriptPhysician profile
Karen Burtt
NPI 1356833644
$715.35
in general payments reported to CMS, 2019-2025
9 companies · $75.97 in 2025
The $75.97 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.75 · 2022: $156 · 2023: $249 · 2024: $210 · 2025: $75.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Heron Therapeutics, INC. | $107.95 | 2024 | Zynrelef |
| Polynovo North America LLC | $102.36 | 2024 | Novosorb Btm |
| Endo Pharmaceuticals INC. | $99.88 | 2023 | Xiaflex |
| Abbvie INC. | $46.09 | 2025 | |
| Alexion Pharmaceuticals, INC. | $31.33 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.88 | 2025 | Journavx |
| Abbott Laboratories | $23.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Burtt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.